Capstone Investment Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $601K | Buy |
+2,836
| New | +$557K | ﹤0.01% | 1156 |
|
|
2025
Q4 | – | Sell |
-5,211
| Closed | -$993K | – | 1707 |
|
|
2025
Q3 | $993K | Sell |
5,211
-519
| -9% | -$92.1K | ﹤0.01% | 1026 |
|
|
2025
Q2 | $1.03M | Buy |
+5,730
| New | +$995K | ﹤0.01% | 844 |
|
|
2025
Q1 | – | Sell |
-5,534
| Closed | -$835K | – | 1466 |
|
|
2024
Q4 | $835K | Buy |
5,534
+2,164
| +64% | +$337K | ﹤0.01% | 1133 |
|
|
2024
Q3 | $523K | Buy |
3,370
+1,029
| +44% | +$154K | ﹤0.01% | 1197 |
|
|
2024
Q2 | $320K | Sell |
2,341
-517
| -18% | -$70.8K | ﹤0.01% | 1557 |
|
|
2024
Q1 | $380K | Buy |
2,858
+2,258
| +376% | +$293K | ﹤0.01% | 1707 |
|
|
2023
Q4 | $82.7K | Sell |
600
-7,751
| -93% | -$1.02M | ﹤0.01% | 1953 |
|
|
2023
Q3 | $1.02M | Buy |
8,351
+8,058
| +2,750% | +$1.07M | ﹤0.01% | 985 |
|
|
2023
Q2 | $41.2K | Sell |
293
-361
| -55% | -$49.8K | ﹤0.01% | 1782 |
|
|
2023
Q1 | $92.5K | Sell |
654
-2,879
| -81% | -$412K | ﹤0.01% | 1377 |
|
|
2022
Q4 | $553K | Sell |
3,533
-9,160
| -72% | -$1.32M | ﹤0.01% | 1086 |
|
|
2022
Q3 | $1.56M | Buy |
12,693
+7,590
| +149% | +$1,000K | 0.01% | 857 |
|
|
2022
Q2 | $679K | Sell |
5,103
-151
| -3% | -$20.6K | ﹤0.01% | 1147 |
|
|
2022
Q1 | $719K | Buy |
+5,254
| New | +$732K | ﹤0.01% | 1417 |
|
|
2021
Q4 | – | Sell |
-9,385
| Closed | -$1.43M | – | 1892 |
|
|
2021
Q3 | $1.36M | Buy |
9,385
+5,435
| +138% | +$795K | ﹤0.01% | 1320 |
|
|
2021
Q2 | $521K | Buy |
3,950
+2,079
| +111% | +$272K | ﹤0.01% | 1371 |
|
|
2021
Q1 | $240K | Sell |
1,871
-6,530
| -78% | -$805K | ﹤0.01% | 1407 |
|
|
2020
Q4 | $1M | Buy |
+8,401
| New | +$1.02M | ﹤0.01% | 1081 |
|
|
2019
Q2 | – | Sell |
-1,538
| Closed | -$148K | – | 1393 |
|
|
2019
Q1 | $138K | Buy |
1,538
+1,483
| +2,696% | +$129K | ﹤0.01% | 1173 |
|
|
2018
Q4 | $5K | Sell |
55
-641
| -92% | -$60.1K | ﹤0.01% | 1236 |
|
|
2018
Q3 | $75K | Buy |
+696
| New | +$76.3K | ﹤0.01% | 1172 |
|
|
2018
Q1 | – | Sell |
-4,200
| Closed | -$413K | – | 376 |
|
|
2017
Q4 | $413K | Buy |
+4,200
| New | +$398K | 0.01% | 303 |
|
|
2016
Q2 | – | Sell |
-6,312
| Closed | -$450K | – | 718 |
|
|
2016
Q1 | $450K | Buy |
+6,312
| New | +$423K | 0.01% | 438 |
|
|
2014
Q1 | – | Sell |
-45,000
| Closed | -$2.41M | – | 413 |
|
|
2013
Q4 | $2.41M | Buy |
+45,000
| New | +$2.67M | 0.03% | 302 |
|
Other funds holding DGX
EIG
Capstone Investment Advisors's DGX Position: Q2 2026 in Review
Capstone Investment Advisors opened a new position in Quest Diagnostics (DGX) in Q2 2026: 2,836 shares worth $601K. The stake represents ﹤0.01% of the portfolio and ranks #1156 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in DGX as recently as Q3 2025.
Capstone Investment Advisors first reported a position in DGX in Q4 2013 and has held it in 25 quarters since. The position peaked at $2.41M in Q4 2013. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Capstone Investment Advisors held 2,836 shares of Quest Diagnostics worth $601K as of Q2 2026.
- Quest Diagnostics was a new Capstone Investment Advisors position in Q2 2026.
- Quest Diagnostics made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1156 holding.
- Capstone Investment Advisors first reported a position in Quest Diagnostics in Q4 2013 and has held it in 25 quarters since.
- Capstone Investment Advisors's Quest Diagnostics position peaked at $2.41M in Q4 2013.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.